Alexander Berger

Alexander Berger

@albrgr.bsky.social

CEO of Coefficient Giving

2K followers654 following458 posts

Alexander Berger reposted

I've seen speculation AI anxieties are behind negative sentiment. Zero evidence for that: 1. Negativity pre-dates AI. 2. People much more negative about prices than jobs. 3. Negativity same across education/age/income groups 4. Negativity much worse in US but AI is everywhere.

We also launched a big specific call for founders for ambitious new AI safety initiatives today: coefficientgiving.org/tailwind/ So much more to be doing here!

coefficientgiving.orgProject TailwindProject Tailwind is Coefficient Giving's call for founders to launch ambitious AI safety initiatives.
Alexander Berger@albrgr.bsky.social

Ahead of the coming "third wave of philanthropy," we want to give hundreds of millions of dollars to "general managers" to lead targeted funds tackling big problems in global health and wellbeing (h/t @nanr.bsky.social for the frame). Apply by October 2: coefficientgiving.org/funds/globa...

View full thread

Bed nets have gotten a lot of attention over the years, but they've stuck around because they work. The WHO estimates 14 million malaria deaths have been averted since 2000, and credits widespread net use with a 70% drop in African malaria cases between 2000 and 2015: www.who.int/teams/globa...

who.intWorld malaria report 2025Each year, WHO’s World malaria report provides a comprehensive and up-to-date assessment of trends in malaria control and elimination across the globe

Alexander Berger reposted

I've spent my career working on vaccines, and until I joined Coefficient Giving, I'd never heard Strep A mentioned as a global health priority. The more I looked, the harder it was to understand why a disease killing 630,000+ people a year was so neglected.

globalhealthnow.orgA Vaccine for Strep A May Finally Be in ReachStrep A—the bacterium behind strep throat and impetigo—kills hundreds of thousands of people a year, mostly young people in LMICs—yet Strep A vaccine R&D is chronically underfunded.

And I'm thrilled to be betting on Katharine's vision here! As a grad student, she co-invented the R21 malaria vaccine that's now reaching millions of kids. I'm hoping to see hundreds of millions of future Strep A vaccine doses with her fingerprints on them.

→ A huge problem: ~1% of total annual deaths worldwide (>600k) → Super neglected: ~$14M/yr of R&D globally before this, ~50x less than malaria which has similar mortality → Newly tractable: new human challenge models and earlier diagnostics should speed the path to an approved vaccine

Grateful to our partners Adam and Abigail Winkel, Good Ventures, Lucy Southworth, The Patchwork Collective, and a few anon donors for getting us to >$140M at launch. We're continuing to actively fundraise and think we could effectively spend >$200M over the next few years.

Nobel laureate Al Roth has a great piece in @washingtonpost.com today on why we should compensate kidney donors. Kidney failure disproportionately hits Black and low-income Americans, costs Medicare $55B+/yr, and most people who need a transplant will die without one. 🧵

View full thread

I'm hopeful that the End Kidney Deaths Act — which would create a pilot program offering a $50K tax credit to people who donate a kidney to a stranger — will move forward this Congress. If you want to help, consider signing the petition at endkidneydeathsact.org

endkidneydeathsact.orgEndKidneyDeathsAct.orgThe End Kidney Deaths Act will end the kidney shortage, save 10,000 lives each year, and reduce taxes by $4 billion by supporting those who donate kidneys to strangers.

Nobel laureate Al Roth has a great piece in @washingtonpost.com today on why we should compensate kidney donors. Kidney failure disproportionately hits Black and low-income Americans, costs Medicare $55B+/yr, and most people who need a transplant will die without one. 🧵

In the coming years, billions in new philanthropic capital could be unlocked. Whether that money is matched to the highest-impact opportunities is far from guaranteed. At CG, we’re hiring for a Managing Director, Philanthropic Advisory to make this influx of capital go as well as possible.

View full thread

In the coming years, billions in new philanthropic capital could be unlocked. Whether that money is matched to the highest-impact opportunities is far from guaranteed. At CG, we’re hiring for a Managing Director, Philanthropic Advisory to make this influx of capital go as well as possible.

View full thread

The ideal candidate is: • Strategically sharp and substantively deep on CG’s cause areas • An effective executive that can build a strong team • An excellent external representative of CG’s work to major donors

In the coming years, billions in new philanthropic capital could be unlocked. Whether that money is matched to the highest-impact opportunities is far from guaranteed. At CG, we’re hiring for a Managing Director, Philanthropic Advisory to make this influx of capital go as well as possible.

I usually end up mostly reading fiction because it's easier and more fun than most nonfiction. But I read "And the Band Played On" recently and loved it. Incredibly info-dense, but extremely well-written and page-turning. Any recs for other great readable nonfiction like this?

Great reporting from @chronphilanthropy.bsky.social on our grantee @cureswithinreach.bsky.social, which runs small trials testing whether existing, approved drugs might work for entirely different diseases.

The Chronicle of Philanthropy@chronphilanthropy.bsky.social

$12 million in grants. $145 million in follow-on funding. The math behind Cures Within Reach is simple: fund the studies no one else will, and bigger funders follow. https://phlnthrp.com/4dsNCFk